ISSN 1518 0557
Use of recombinant luteinizing hormone for controlled ovarian hyperstimulation in infertile patients

2016; 20
Mônica Canedo Silva Maia, Mário Silva Approbato, Tatiana M. da Silva, Eliamar A. de B. Fleury, Eliane Gouveia de Moraes Sanchez, Reinaldo S. Azevedo Sasaki
JBRA Assist. Reprod. 2016; 20 (2):78-81

Received October 10, 2015
Accepted May 17, 2016
Abstract

Controlled ovarian stimulation has become an integral part of a high complexity infertility treatment. Treatment options with recombinant gonadotrophins add more to knowledge on folliculogenesis and ovarian steroidogenesis. Therefore, a literature search was conducted in the following data bases: Medline, Scielo and PubMed. The descriptors/key words used were ovarian stimulation, in vitro fertilization, recombinant luteinizing hormone, supplementation LH. The aim of this study was to review the available literature and to assess the benefits of using recombinant luteinizing hormone associated with recombinant follicle stimulating hormone in different populations who have undergone assisted reproduction procedures.


This Article

doi: 10.5935/1518-0557.20160018

Full Text (HTML)
Full Text (PDF)

Classifications

Review

How to cite

How to cite this article

Send this article

Send this article by mail

Access statistics

Last 30 days: 51
All time: 4533


Home

 
Copyright 2026 - JBRA Assisted Reproduction - All rights reserved.
Support and Maintenance by Eniosoft